ONLINE DATABASE SEARCH - HIV-LS-360-MEMO
1. 59270 HIV-LS-360; PUBMED-HIV-10/30/2006
3'-Carbon-substituted pyrimidine nucleosides having a 2',3'-dideoxy and 2',3'-didehydro-2',3'-dideoxy structure: synthesis and antiviral evaluation
Kumamoto, H, Onuma, S, Tanaka, H, Dutschman, GE, and Cheng, YC
Antivir Chem Chemother 2006. 17(4): 225-34
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17066900&dopt=abstract
2. 59271 HIV-LS-360; PUBMED-HIV-10/30/2006
Novel Antiretroviral Agents in HIV Therapy
Reed, C and Daar, ES
Curr Infect Dis Rep 2006. 8(6): 489-96
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17064643&dopt=abstract
3. 59272 HIV-LS-360; PUBMED-HIV-10/30/2006
The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells
Wang, J, Shackelford, JM, Casella, CR, Shivers, DK, Rapaport, EL, Liu, B, Yu, XF, and Finkel, TH
Virology 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17056089&dopt=abstract
4. 59273 HIV-LS-360; PUBMED-HIV-10/30/2006
Luman, a New Partner of HIV-1 TMgp41, Interferes with Tat-mediated Transcription of the HIV-1 LTR
Blot, G, Lopez-Verges, S, Treand, C, Kubat, NJ, Delcroix-Genete, D, Emiliani, S, Benarous, R, and Berlioz-Torrent, C
J Mol Biol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17054986&dopt=abstract
5. 59274 HIV-LS-360; PUBMED-HIV-10/30/2006
Computational Study of the Interaction between TIBO Inhibitors and Y181 (C181), K101, and Y188 Amino Acids
Freitas, RF and Galembeck, SE
J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2006. 110(42): 21287-98
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17048958&dopt=abstract
6. 59275 HIV-LS-360; PUBMED-HIV-10/30/2006
Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking
Neffe, AT, Bilang, M, and Meyer, B
Org Biomol Chem 2006. 4(17): 3259-67
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17036114&dopt=abstract
7. 59276 HIV-LS-360; PUBMED-HIV-10/30/2006
Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama Bay
Lee, JB, Hayashi, K, Hirata, M, Kuroda, E, Suzuki, E, Kubo, Y, and Hayashi, T
Biol Pharm Bull 2006. 29(10): 2135-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17015966&dopt=abstract
8. 59277 HIV-LS-360; PUBMED-HIV-10/30/2006
The triphosphate of beta-d-4'-C-ethynyl-2',3'-dideoxycytidine is the preferred enantiomer substrate for HIV reverse transcriptase
Siddiqui, MA and Marquez, VE
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17046266&dopt=abstract
9. 59278 HIV-LS-360; WOS-HIV-10/22/2006
Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives
Pungpo, P, Saparpakorn, P, Wolschann, P, and Hannongbua, S
SAR AND QSAR IN ENVIRONMENTAL RESEARCH 2006. 17(4): 353-370, 18
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240953700001
10. 59279 HIV-LS-360; EMBASE-HIV-10/30/2006
Inhibition of HIV-1 Gene Expression by a Fragment of hnRNP U
Valente, Susana T and Goff, Stephen P
Molecular Cell 2006. 23(4): 597-605
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WSR-4KNKTTM-G/2/064b99fa114806683e0c13e6f7d0e0c8
11. 59280 HIV-LS-360; EMBASE-HIV-10/30/2006
Amino acid insertions at position 35 of HIV-1 protease interfere with virus replication without modifying antiviral drug susceptibility
Paolucci, Stefania, Baldanti, Fausto, Dossena, Luca, and Gerna, Giuseppe
Antiviral Research 2006. 69(3): 181-185
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4J32H1X-1/2/bf2938402a0d88a2b8ff66d56d5d2fee
12. 59281 HIV-LS-360; EMBASE-HIV-10/30/2006
A 4D-QSAR study on anti-HIV HEPT analogues
Bak, Andrzej and Polanski, Jaroslaw
Bioorganic & Medicinal Chemistry 2006. 14(1): 273-279
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4H68NJT-D/2/7e00f0545b1bf4150d4323d47845d0f2
13. 59282 HIV-LS-360; WOS-HIV-10/22/2006
Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA
Konstantinova, P, de Vries, W, Haasnoot, J, ter Brake, O, de Haan, P, and Berkhout, B
GENE THERAPY 2006. 13(19): 1403-1413, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240942700005
14. 59283 HIV-LS-360; WOS-HIV-10/22/2006
HIV type 1 inhibition by protein kinase C modulatory compounds
Warrilow, D, Gardner, J, Darnell, GA, Suhrbier, A, and Harrich, D
AIDS RESEARCH AND HUMAN RETROVIRUSES 2006. 22(9): 854-864, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240946700006
15. 59284 HIV-LS-360; WOS-HIV-10/22/2006
A nonneutralizing anti-HIV type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN
Lee, SJ, Arora, R, Bull, LM, Arduino, RC, Garza, L, Allan, J, Kimata, JT, and Zhou, P
AIDS RESEARCH AND HUMAN RETROVIRUSES 2006. 22(9): 874-883, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240946700009
16. 59285 HIV-LS-360; WOS-HIV-10/30/2006
Synthesis of l-(alkoxymethyl)-5-benzyl-6-methyluracil as potential nonnucleoside HIV-1 RT inhibitors
Chen, YL, Guo, Y, Yang, H, Wang, XW, and Liu, JY
SYNTHETIC COMMUNICATIONS 2006. 36(19): 2913-2920, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241196300019
17. 59286 HIV-LS-360; WOS-HIV-10/30/2006
In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L
Gerencer, M, Turecek, PL, Kistner, O, Mitterer, A, Savidis-Dacho, H, and Barrett, NP
ANTIVIRAL RESEARCH 2006. 72(2): 153-156, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241092900009
18. 59287 HIV-LS-360; WOS-HIV-10/30/2006
Switching from protease inhibitor-based-HAART to a protease inhibitor-sparing regimen is associated with improved specific HIV-immune responses in HIV-infected children
Pensieroso, S, Romiti, ML, Palma, P, Castelli-Gattinara, G, Bernardi, S, Freda, E, Rossi, P, and Cancrini, C
AIDS 2006. 20 (14): 1893-1896, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000241071800015